Menu5/4/20: While eyes are justifiably on testing and COVID-19, Genova Diagnostics Inc, a clinical laboratory services company, recently entered into a settlement agreement with the US Department of Justice that will cost the company some $43 million. The settlement resolves allegations by DOJ that the company violated the False Claims Act by billing government-funded healthcare programs including Medicare and Medicaid for medically unnecessary tests...
The settlement also resolves violations of the physician self-referral provision of the Stark Act. Along with the financial hit, the company will be subject to a five-year corporate integrity agreement with the Department of Health and Human Services Office of Inspector General...
